Related Experiment Video
Updated: Aug 2, 2025
Optimized Management of Endovascular Treatment for Acute Ischemic Stroke
Published on: January 18, 2018
Advances in the Diagnosis and Treatment of Pediatric Arterial Ischemic Stroke
1Divisions of Pediatric Neurology and Cerebrovascular Neurology, Department of Neurology, Johns Hopkins University School of Medicine, 200 N. Wolfe Street, Ste 2158, Baltimore, MD, 21287, USA. lsun20@jhmi.edu.
Insights
Pediatric stroke, though rare, significantly impacts child mortality and morbidity. Advances in neuroimaging and stroke protocols enable faster diagnosis and etiology determination, supporting consideration of acute therapies.
Area of Science:
- Pediatric Neurology
- Neuroscience
- Child Health
Background:
- Stroke in infants and children is a critical cause of mortality and long-term disability.
- Advances in neuroimaging and stroke care protocols have improved diagnosis and etiological identification.
- While data on hyperacute therapies in pediatric stroke are limited, feasibility and safety are increasingly recognized.
Purpose of the Study:
- To review current understanding and advances in pediatric stroke diagnosis and treatment.
- To highlight recent therapeutic progress in stroke prevention for high-risk pediatric conditions.
- To identify persistent knowledge gaps in the optimal management of childhood stroke.
Main Methods:
- Review of neuroimaging advancements and pediatric stroke care protocols.
- Analysis of emerging data on intravenous thrombolysis and mechanical thrombectomy in children.
- Examination of recent therapeutic strategies for stroke prevention in specific pediatric conditions.
- Identification of ongoing research needs and knowledge gaps.
Main Results:
- Neuroimaging and protocols facilitate rapid diagnosis and etiology determination in pediatric stroke.
- Feasibility and safety data for hyperacute therapies (thrombolysis, thrombectomy) are growing.
- Targeted prevention strategies are available for high-risk conditions like moyamoya and sickle cell disease.
Conclusions:
- Hyperacute therapies for pediatric stroke warrant careful consideration based on accumulating data.
- Significant knowledge gaps remain regarding optimal thrombolytic agents, thrombectomy criteria, immunomodulatory therapies, antithrombotic strategies, PFO closure, and rehabilitation.
- Further research is crucial to optimize the management and outcomes of pediatric stroke.
Abstract:
Though rare, stroke in infants and children is an important cause of mortality and chronic morbidity in the pediatric population. Neuroimaging advances and implementation of pediatric stroke care protocols have led to the ability to rapidly diagnose stroke and in many cases determine the stroke etiology. Though data on efficacy of hyperacute therapies, such as intravenous thrombolysis and mechanical thrombectomy, in pediatric stroke are limited, feasibility and safety data are mounting and support careful consideration of these treatments for childhood stroke. Recent therapeutic advances allow for targeted stroke prevention efforts in high-risk conditions, such as moyamoya, sickle cell disease, cardiac disease, and genetic disorders. Despite these exciting advances, important knowledge gaps persist, including optimal dosing and type of thrombolytic agents, inclusion criteria for mechanical thrombectomy, the role of immunomodulatory therapies for focal cerebral arteriopathy, optimal long-term antithrombotic strategies, the role of patent foramen ovale closure in pediatric stroke, and optimal rehabilitation strategies after stroke of the developing brain.
Related Concept Videos
01:27Peripheral Artery Disease III: Interprofessional Care
01:21Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
01:23Atherosclerosis IV: Nursing Management
01:27Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
01:30Acute Kidney Injury IV: Diagnostic Studies and Prevention